Venus Medtech has announced that patient enrolment has been completed in its confirmatory clinical trial for the Venus-PowerX transcatheter aortic valve implantation (TAVI) system. The Venus-PowerX PREVAILS study is a prospective, multicentre, single-arm, objective‑performance‑criterion trial designed to evaluate the safety, efficacy, and device performance of the Venus-PowerX system in patients with severe aortic stenosis. Venus […] The post Patient enrolment completed in trial of self-expanding dry-valve TAVI device appeared first on Cardiovascular News .